IndiaTickerLatest filing: General Updates - Mankind Pharma Limited
ObservedCompany dossier
Mankind Pharma
NSE:MANKIND · ISIN INE634S01028
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Mankind Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Mar 2026 · revenue ₹3,442.9 Cr · PAT ₹559.4 Cr.
Exchange XBRLLatest ownership: promoter group 72.63% and public 27.37% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Mankind Pharma Limited: Ratings reaffirmed for existing instruments and assigned for commercial paper programme
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing General Updates - Mankind Pharma Limited
NSE · exchange filing
Observed
Source filing Mankind Pharma Ltd - 543904 - Final Update On Stake Sale Of Broadway Hospitality Services Private Limited
BSE · exchange filing
Observed
Archived filing Analysts/Institutional Investor Meet/Con. Call Updates - Mankind Pharma Limited
NSE · conference call
Observed
Archived filing Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE · conference call
Reported financials
Full financials →31 Mar 2026
- Revenue from operations
- ₹3,442.9 Cr
- Profit after tax
- ₹559.4 Cr
- EPS
- ₹13.44
Observed BSE structured filing · consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 72.63%
- Public
- 27.37%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL